health
Whole-genome sequencing yields a T-cell score linked to immunotherapy outcomes
A bioRxiv preprint describes CIDER, a whole-genome sequencing score based on reconstructed T-cell receptor sequences. In patient cohorts, higher scores were associated with better outcomes among people treated with immune checkpoint inhibitors.
